These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Diabetic kidney disease: act now or pay later. Atkins RC; Zimmet P Nephrol Dial Transplant; 2010 Feb; 25(2):331-3. PubMed ID: 20093271 [No Abstract] [Full Text] [Related]
23. Diabetic kidney disease: act now or pay later. Atkins RC; Zimmet P Nephrology (Carlton); 2010 Feb; 15(1):20-2. PubMed ID: 20377766 [No Abstract] [Full Text] [Related]
24. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?]. Luño J; Valderrábano F An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851 [No Abstract] [Full Text] [Related]
25. [Effects of temocapril on the prevention of early diabetic nephropathy in OLETF rat, an animal model for type 2 diabetes]. Masuda H Hokkaido Igaku Zasshi; 2002 Sep; 77(5):419-28. PubMed ID: 12404757 [No Abstract] [Full Text] [Related]
26. Angiotensin-Il-receptor blockers and nephropathy in patients with type 2 diabetes. Farquhar D CMAJ; 2001 Nov; 165(10):1379. PubMed ID: 11760990 [No Abstract] [Full Text] [Related]
27. [Losartan and the kidney protection. The RENAAL study]. Recenti Prog Med; 2001 Dec; 92(12):788. PubMed ID: 11822103 [No Abstract] [Full Text] [Related]
28. Chronic complications of diabetes: a creative management approach. Eaks GA; Tiszka R Nurse Pract Forum; 1998 Jun; 9(2):74-86. PubMed ID: 9752122 [TBL] [Abstract][Full Text] [Related]
29. [Routine screening for microalbuminemia in type 2 diabetes mellitus--con]. Sawicki PT Dtsch Med Wochenschr; 2003 May; 128(21):1188. PubMed ID: 12761693 [No Abstract] [Full Text] [Related]
30. [Routine screening for microalbuminemia in type 2 diabetes mellitus--pro]. Dikow R; Ritz E Dtsch Med Wochenschr; 2003 May; 128(21):1187. PubMed ID: 12761692 [No Abstract] [Full Text] [Related]
31. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus. Postma MJ; de Zeeuw D Nephrol Dial Transplant; 2009 Oct; 24(10):2975-83. PubMed ID: 19605601 [No Abstract] [Full Text] [Related]
32. [Inhibition of the renin-angiotensin system in type 2 diabetes. New significant results concerning type 2 diabetes and renal disease]. Mogensen CE Ugeskr Laeger; 2001 Oct; 163(40):5488. PubMed ID: 11601112 [No Abstract] [Full Text] [Related]
34. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198 [TBL] [Abstract][Full Text] [Related]
35. Diabetic kidney disease: act now or pay later. Atkins RC; Zimmet PZ; ; ; Med J Aust; 2010 Mar; 192(5):272-4. PubMed ID: 20201761 [TBL] [Abstract][Full Text] [Related]
36. Kidney disease ups heart risk: here's help. Johns Hopkins Med Lett Health After 50; 2007 Jan; 18(11):3, 7. PubMed ID: 17323492 [No Abstract] [Full Text] [Related]
40. [Current guidelines for the prevention and treatment of diabetic nephropathy. International Diabetes Federation]. Bilo HJ Ned Tijdschr Geneeskd; 1995 Sep; 139(36):1847-9. PubMed ID: 7477510 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]